Abstract
Cd79a (called mb-1 here) encodes the Ig-α signaling component of the B cell receptor. The early B cell–specific mb-1 promoter was hypermethylated at CpG dinucleotides in hematopoietic stem cells but became progressively unmethylated as B cell development proceeded. The transcription factor Pax5 activated endogenous mb-1 transcription in a plasmacytoma cell line, but could not when the promoter was methylated. In this context, early B cell factor (EBF), a transcription factor required for B lymphopoiesis, potentiated activation of mb-1 by Pax5. EBF and the basic helix-loop-helix transcription factor E47 each contributed to epigenetic modifications of the mb-1 promoter, including CpG demethylation and nucleosomal remodeling. EBF function was enhanced by interaction with the transcription factor Runx1. These data suggest a molecular basis for the hierarchical dependence of Pax5 function on EBF and E2A in B lymphocyte development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
References
Wang, Q. et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93, 3444–3449 (1996).
Okuda, T., van Deursen, J., Hiebert, S., Grosveld, G. & Downing, J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321–330 (1996).
Wang, Q. et al. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell 87, 697–708 (1996).
Zhang, D.E. et al. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell Biol. 16, 1231–1240 (1996).
Taniuchi, I. et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111, 621–633 (2002).
Libermann, T.A. et al. AML1 (CBFα2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter. J. Biol. Chem. 274, 24671–24676 (1999).
Ichikawa, M. et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10, 299–304 (2004).
Borghesi, L. et al. B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors. J. Exp. Med. 199, 491–502 (2004).
Bain, G. et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885–892 (1994).
Lin, H. & Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263–267 (1995).
Urbanek, P., Wang, Z.Q., Fetka, I., Wagner, E.F. & Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901–912 (1994).
Hagman, J., Belanger, C., Travis, A., Turck, C.W. & Grosschedl, R. Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression. Genes Dev. 7, 760–773 (1993).
Hagman, J., Travis, A. & Grosschedl, R. A novel lineage-specific nuclear factor regulates mb-1 gene transcription at the early stages of B cell differentiation. EMBO J. 10, 3409–3417 (1991).
O'Riordan, M. & Grosschedl, R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11, 21–31 (1999).
Sigvardsson, M. Overlapping expression of early B-cell factor and basic helix-loop-helix proteins as a mechanism to dictate B-lineage-specific activity of the lambda5 promoter. Mol. Cell Biol. 20, 3640–3654 (2000).
Goebel, P. et al. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J. Exp. Med. 194, 645–656 (2001).
Sigvardsson, M. et al. Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter. Mol. Cell Biol. 22, 8539–8551 (2002).
Gisler, R. & Sigvardsson, M. The human VpreB promoter is a target for coordinated activation by early B cell factor and E47. J. Immunol. 168, 5130–5138 (2002).
Sigvardsson, M., O'Riordan, M. & Grosschedl, R. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7, 25–36 (1997).
Fitzsimmons, D. et al. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10, 2198–2211 (1996).
Maier, H., Colbert, J., Fitzsimmons, D., Clark, D.R. & Hagman, J. Activation of the early B-cell-specific mb-1 (Ig-α) gene by Pax-5 is dependent on an unmethylated Ets binding site. Mol. Cell Biol. 23, 1946–1960 (2003).
Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D. & Hayakawa, K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173, 1213–1225 (1991).
Gonzalgo, M.L. & Jones, P.A. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (MS-SNuPE). Nucleic Acids Res. 25, 2529–2531 (1997).
Wotton, D., Ghysdael, J., Wang, S., Speck, N.A. & Owen, M.J. Cooperative binding of Ets-1 and core binding factor to DNA. Mol. Cell Biol. 14, 840–850 (1994).
Schebesta, M., Heavey, B. & Busslinger, M. Transcriptional control of B-cell development. Curr. Opin. Immunol. 14, 216–223 (2002).
Maier, H. et al. Requirements for selective recruitment of Ets proteins and activation of mb-1/Ig-α gene transcription by Pax-5 (BSAP). Nucleic Acids Res. 31, 5483–5489 (2003).
Hombach, J., Leclercq, L., Radbruch, A., Rajewsky, K. & Reth, M. A novel 34-kd protein co-isolated with the IgM molecule in surface IgM-expressing cells. EMBO J. 7, 3451–3456 (1988).
Hombach, J., Sablitzky, F., Rajewsky, K. & Reth, M. Transfected plasmacytoma cells do not transport the membrane form of IgM to the cell surface. J. Exp. Med. 167, 652–657 (1988).
Ikawa, T., Kawamoto, H., Wright, L.Y.T. & Murre, C. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 20, 349–360 (2004).
Seet, C.S., Brumbaugh, R.L. & Kee, B.L. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J. Exp. Med. 199, 1689–1700 (2004).
Travis, A., Hagman, J. & Grosschedl, R. Heterogeneously initiated transcription from the pre-B- and B-cell-specific mb-1 promoter: analysis of the requirement for upstream factor-binding sites and initiation site sequences. Mol. Cell Biol. 11, 5756–5766 (1991).
Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765–771 (1997).
Inoue, K. et al. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat. Neurosci. 5, 946–954 (2002).
Levanon, D. et al. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21, 3454–3463 (2002).
Li, Q.L. et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109, 113–124 (2002).
Meyers, S., Lenny, N., Sun, W. & Hiebert, S.W. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13, 303–312 (1996).
Romanow, W.J. et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5, 343–353 (2000).
Lundgren, M. et al. Transcription factor dosage affects changes in higher order chromatin structure associated with activation of a heterochromatic gene. Cell 103, 733–743 (2000).
Medina, K.L. et al. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell (in the press).
Julius, M.H., Janusz, M. & Lisowski, J. A colostral protein that induces the growth and differentiation of resting B lymphocytes. J. Immunol. 140, 1366–1371 (1988).
Swift, S., Lorens, J., Achacoso, P. & Nolan, G.P. in Current Protocols in Immunology (Online) (eds. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. & Strober, W.) Unit 10.17C (John Wiley & Sons, New York, 2003).
Quong, M.W., Harris, D.P., Swain, S.L. & Murre, C. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18, 6307–6318 (1999).
Hawley, R.G., Lieu, F.H., Fong, A.Z. & Hawley, T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Therapy 1, 136–138 (1994).
Naviaux, R.K., Constanzi, E., Haas, M. & Verma, I.M. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70, 5701–5705 (1996).
Wagner, D.H., Jr. et al. Thymocytes are rescued from glucocorticoid-mediated cell death by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2. J. Exp. Med. 184, 1631–1638 (1996).
Schreiber, E., Matthias, P., Muller, M.M. & Schaffner, W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17, 6419 (1989).
Acknowledgements
The authors thank P. Kincade (Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma) for providing the SB199 hybridoma; M. Reth (Max-Planck Institute, Tubingen, Germany) for providing the 558LμM cell line; M. Busslinger (Institute for Molecular Pathology, Vienna, Austria) for providing the Pax5−/− mice; and S. McNeff for assistance with illustrations. Supported by National Institutes of Health (T32 AI07405 to H.M.; R01 AI26782 and R01 AI40946 to R.R.H.; and P01 AI22295, R01 AI054661 and R01 AI056322 to J.H.), the Irvington Institute for Immunological Research (K.L.M.) and the Milheim Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
EBF and Runx1/CBFβ synergistically activate the mb-1 promoter. (PDF 88 kb)
Supplementary Fig. 2
Real-time PCR analyses of Tcfe2a−/− pre-pro-B cells transduced with control, EBF or E47-expressing retroviruses. (PDF 128 kb)
Rights and permissions
About this article
Cite this article
Maier, H., Ostraat, R., Gao, H. et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol 5, 1069–1077 (2004). https://doi.org/10.1038/ni1119
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1119